Article
Characteristics of the clinicopathology and immune microenvironment of the basal-like phenotype in HR+/HER2-breast cancer
2022-02-14
Abstract excerpt
<h4>Background: </h4> Expression of basal-like markers (BMs) is usually observed in triple-negative breast cancer (TNBC) and HER2-overexpressing breast cancer and is related to poor prognosis. Recently, some have reported that BM is expressed in 7.8%-27.1% of HR+/HER2- breast cancers (basal-like phenotype, BM+ BCs), but their biological behaviours remain controversial. This study aimed to compare the differences i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 566853ed-7f2e-545e-b003-d579f7ee5239
- DOI
- 10.21203/rs.3.rs-1338624/v1
